Pharmaceutical Supply Procurement for Jalandhar Military Operations

This tender, issued by the Department of Military Affairs under the Ministry of Defence, and organized by the Indian Army, concerns the procurement of a comprehensive range of pharmaceutical supplies for its Jalandhar City operations. The bid, identified by number GEM/2026/B/8030649, opens on November 8, 2026, at 6:00 PM and closes on November 9, 2026, at 6:00 PM. The overall requirement encompasses a total quantity of 77,600 units across various essential medications, including but not limited to, Oxcarbazepine ER 600 mg, Atomoxetine 10 mg, Clomiphene Citrate 50 mg, Lamotrigine 50 mg, Memantine 5 mg, Risperidone 4 mg, Topiramate (25 mg and 50 mg), Rizatriptan 5 mg, Amitriptyline 25 mg, Doxepin HCl 75 mg (capsule), Venlafaxine 75 mg, Lithium Carbonate SR 400 mg, Thyroxine Sodium (0.025 mg and 50 mcg), Potassium Citrate (1100 mg with Citric acid or Magcitrate), a combination of Zidovudine 300 mg plus Lamivudine 150 mg, and Clarithromycin 250 mg. This vital procurement aims to ensure the continued health and well-being of personnel by providing critical and diverse pharmaceutical products.